Press Releases
Alliance for Cancer Gene Therapy funds development of remote-control CAR T-cell therapy
Crystal Mackall, MD, receives her second research grant from foundation. STAMFORD, Conn., July 2, 2024 — A $500,000 grant from Alliance for Cancer Gene Therapy (ACGT) will support Stanford University scientists who are developing a CAR…
Alliance for Cancer Gene Therapy funds the development of promising oncolytic virus approach for glioblastoma
E. Antonio Chiocca, MD, PhD, receives his second research grant from foundation. STAMFORD, Conn., Feb. 13, 2024 — Thanks to a second $500,000 grant from Alliance for Cancer Gene Therapy (ACGT), scientists at Brigham and Women’s…
Alliance for Cancer Gene Therapy grows Scientific Advisory Council with two new members.
Drs. Pilon-Thomas and Rezvani are cell and gene therapy researchers at world-class cancer centers. STAMFORD, Conn., Jan. 9, 2024 — Alliance for Cancer Gene Therapy (ACGT) welcomes Shari Pilon-Thomas, PhD (Moffitt Cancer Center), and Katy Rezvani,…
Alliance for Cancer Gene Therapy adds Dr. Bruce Levine to Board of Directors
Dr. Levine is co-inventor of the first CAR T-cell therapy approved to treat cancer. STAMFORD, Conn., Jan. 9, 2024 — Alliance for Cancer Gene Therapy (ACGT) welcomes Bruce L. Levine, PhD (University of Pennsylvania), to the…
Alliance for Cancer Gene Therapy awards grant for oncolytic virus therapy to treat glioblastoma.
The grant will support scientists working to make a virus more effective for more patients with this brain tumor. STAMFORD, Conn., June 7, 2023 — Thanks to a $500,000 grant from Alliance for Cancer Gene Therapy…
ACGT Awards Luncheon honors Dr. Crystal Mackall, features keynote from Siddhartha Mukherjee
Alliance for Cancer Gene Therapy (ACGT) awarded The Edward Netter Leadership Award to Crystal Mackall, MD, of Stanford University, at the ACGT Awards Luncheon on March 30 at Riverpark restaurant at the Alexandria Center for Life…
Alliance for Cancer Gene Therapy awards grant to support new cell therapy clinical trial for pediatric brain cancer
Using a novel TCR therapy to treat children with a rare brain tumor. STAMFORD, Conn., April 6, 2023 — Thanks to a $500,000 grant from Alliance for Cancer Gene Therapy (ACGT), scientists at the University of…
Alliance for Cancer Gene Therapy to honor Dr. Crystal Mackall with Edward Netter Leadership Award
In addition to being an ACGT Research Fellow and a member of ACGT’s Scientific Advisory Council, Dr. Mackall is the Ernest and Amelia Gallo Family Professor of Pediatrics and Medicine at Stanford University, the Founding Director…
ACGT Awards Luncheon to celebrate nonprofit’s 20th anniversary
ACGT funds innovative scientists and biotechnology companies working to harness the power of cell and gene therapy to transform how cancer is treated and to drive momentum toward a cure. 100% of all public donations directly…
ACGT awards grant to advance strategies for treating lung cancer
Recipient Mount Sinai approaching a potential breakthrough in the fight against solid tumors A scientific team led by Brian Brown, PhD, Professor of Genetics and Genomic Sciences and Associate Director of the Precision Immunology Institute at…
Michael T. Lotze, MD, of University of Pittsburgh School Of Medicine named Chair of ACGT Scientific Advisory Council
STAMFORD, Conn., November 19, 2020 — Alliance for Cancer Cell and Gene Therapy (ACGT) announces that Michael T. Lotze, MD, immunologist at UPMC Hillman Cancer Center and professor of surgery, immunology and bioengineering at the University of Pittsburgh…
Yale Cancer Center grant
STAMFORD, Conn. — With a $500,000 Research Grant from Alliance for Cancer Gene Therapy (ACGT), Sidi Chen, PhD, assistant professor in the Department of Genetics and Systems Biology Institute at Yale School of Medicine and member…
University Of Pennsylvania receives ACGT grant
STAMFORD, Conn. — A scientific team is developing a new CAR T-cell gene therapy treatment for advanced metastatic prostate cancer at the Abramson Cancer Center of the University of Pennsylvania (Philadelphia, Pennsylvania) with a $500,000 grant…
